Combination Therapy of Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair

Trial Profile

Combination Therapy of Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair

Recruiting
Phase of Trial: Phase I

Latest Information Update: 25 Jan 2018

At a glance

  • Drugs Irinotecan (Primary) ; Rucaparib (Primary)
  • Indications Solid tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Jan 2018 Status changed from not yet recruiting to recruiting.
    • 27 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top